Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Department of Cardiology, School of Medicine & Institute of Medical Science, Keimyung University, Daegu, Korea.
J Korean Med Sci. 2021 Aug 16;36(32):e229. doi: 10.3346/jkms.2021.36.e229.
Increasing rates of coronavirus disease 2019 (COVID-19) vaccination coverage will result in more vaccine-related side effects, including acute myocarditis. In Korea, we present a 24-year-old male with acute myocarditis following COVID-19 vaccination (BNT162b2). His chest pain developed the day after vaccination and cardiac biomarkers were elevated. Echocardiography showed minimal pericardial effusion but normal myocardial contractility. Electrocardiography revealed diffuse ST elevation in lead II, and V2-5. Cardiac magnetic resonance images showed the high signal intensity of T2- short tau inversion recovery image, the high value of T2 mapping sequence, and late gadolinium enhancement in basal inferior and inferolateral wall. It was presumed that COVID-19 mRNA vaccination was probably responsible for acute myocarditis. Clinical course of the patient was favorable and he was discharged without any adverse event.
新型冠状病毒疾病 2019(COVID-19)疫苗接种覆盖率的增加将导致更多与疫苗相关的副作用,包括急性心肌炎。在韩国,我们报告了一例 COVID-19 疫苗(BNT162b2)接种后发生急性心肌炎的 24 岁男性病例。他在接种疫苗后第二天出现胸痛,且心脏生物标志物升高。超声心动图显示少量心包积液,但心肌收缩力正常。心电图显示 II 导联和 V2-5 导联弥漫性 ST 段抬高。心脏磁共振成像显示 T2-短 tau 反转恢复图像的高信号强度、T2 映射序列的高值和基底下壁和下侧壁的延迟钆增强。推测 COVID-19 mRNA 疫苗接种可能导致急性心肌炎。患者的临床病程良好,无不良事件出院。